Werewolf Therapeutics, Inc. (HOWL) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $254.0K | -67.0% |
| 2023 | $769.0K | -78.7% |
| 2022 | $3.61M | +625.1% |
| 2021 | $498.0K | -11.1% |
| 2020 | $560.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $254.0K | -67.0% |
| 2023 | $769.0K | -78.7% |
| 2022 | $3.61M | +625.1% |
| 2021 | $498.0K | -11.1% |
| 2020 | $560.0K | — |